Necitumumab is a second-generation fully humanized immunoglobulin G1 (IgG1), epidermal growth factor (EGFR) receptor monoclonal antibody that specifically blocks the ligand binding site of EGFR.
Purity:
>99.0%
CAS Number:
[906805-06-9]
* VAT and and shipping costs not included. Errors and price changes excepted